Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2014

Sep 24, 2014

30237_dirs_2014-09-24_16d142a4-96a0-4801-b1e9-436a9bdb7f42.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2014-09-22

Reporting Person: KING DAVID P (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-09-22 Common Stock M 65234 $75.63 Acquired 120816.5841 Direct
2014-09-22 Common Stock S 60534 $104.6442 Disposed 60282.5841 Direct
2014-09-22 Common Stock S 4700 $105.5795 Disposed 55582.5841 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-09-22 Non-qualified Stock Options $75.63 M 65234 Disposed 2018-05-07 Common Stock (0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 31223 Indirect
Common Stock 27296 Indirect

Footnotes

F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F2: The price of $104.6442 per share represents a weighted average of sales prices ranging from $104.24 to $105.23 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F3: The price of $105.5795 per share represents a weighted average of sales prices ranging from $105.26 to $105.93 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F4: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.

F5: The option vested in three equal annual installments beginning on 05/7/2009 and is now fully exercisable.